The role of impaired transport in (pre)clinical resistance to methotrexate: insights on new antifolates

This publication has 33 references indexed in Scilit:

• Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia
  Critical Reviews in Oncology/Hematology, 1997
• Leading Article: Oncologic, Endocrine & Metabolic: New antimetabolites in preclinical and clinical development
  Expert Opinion on Investigational Drugs, 1996
• Characterization of a Mutation in the Reduced Folate Carrier in a Transport Defective L1210 Murine Leukemia Cell Line
  Published by Elsevier ,1995
• Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
  Journal of Clinical Investigation, 1994
• Characterization by flow cytometry and fluorescein-methotrexate labeling of hydrophilic and lipophilic antifolate resistance in cultured mammalian cells
  Anti-Cancer Drugs, 1993
• Edatrexate, an Antifolate with Antitumor Activity: A Review
  Cancer Investigation, 1993
• Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
  Science, 1992
• Megaloblastic hematopoiesis in vitro. Interaction of anti-folate receptor antibodies with hematopoietic progenitor cells leads to a proliferative response independent of megaloblastic changes.
  Journal of Clinical Investigation, 1991
• Lack of Dihydrofolate Reductase in Human Tumor and Leukemia CellsIn Vivo
  Cancer Drug Delivery, 1985
• Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)
  New England Journal of Medicine, 1948